Side Effect Management
Autoinjector Version of Udenyca FDA Approved to Reduce Infection Risk After Myelosuppressive Chemo
This updated administration of Udenyca allows patients to receive this treatment in the office or at home.
Managing Chemotherapy-Induced Hair Loss
Many survivors see significant hair changes during cancer treatment, leaving a difficult reminder when they look in the mirror.
Latino Children With Cancer May Be at an Increased Risk for Neurotoxicity
Latino patients with acute lymphoblastic leukemia and a high level of serum creatine may have an almost six-fold increased risk of neurotoxicity.
Cancer-Related Hair Loss the Second Time Around
I didn’t think that I’d lose my hair again after starting my latest breast cancer treatment, but I did — and with that hair loss came both new and familiar feelings.
MRI May Predict Heart Complications After Cancer Treatment
Patients who experience cardiovascular side effects, such as shortness of breath or chest pain, after cancer treatment should speak with their health care provider about further heart testing.
Blood Cancer Survivor Discusses Clinical Trial Participation, Unexpected Side Effects
Karen Estrada was shocked when she was diagnosed with leukemia and ended up on a lifesaving clinical trial, although her journey was not entirely smooth.
A Better Treatment May Exist for Immunotherapy-Related Heart Problems
Standard corticosteroid use may not be the best treatment for patients with cancer who experience immunotherapy-related heart issues, research showed.
Ointment Being Studied for Hand-Foot Skin Reaction Related to Kidney Cancer Treatment
A clinical trial is currently enrolling patients who are experiencing hand-foot skin reaction as a result of kidney cancer treatment.
Anthracyclines May Increase Heart Failure in Patients with Breast Cancer, Lymphoma
Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.
Oral Mucositis Drug Is Under Review by the FDA
The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer.